Hot take: there's alpha in buying dividend cuts
Here's a contrarian belief I hold: dividend cuts are almost always good, because they extend the life and increase the terminal value of the company.
However, the market almost always punishes companies that cut dividends. There are two reasons for that:
1) A lot of investors don't read financial reports and...
Medifast's stock has slid over 80% from its 2021 high, putting its major valuation metrics at levels comparable to 2008, 2011, and 2020.
Despite the massive decline, the company's financial position still seems to be quite sound - big cash position, healthy current ratio, massive profit margin and return on capital. On top of that, any long-term investor is...
NYSE:MED is a company with a good perspectives on a long distance (1-2 years) with a stable metrics. On the short path (about 3 months) it can show more or less than 100% of price growth, which can be a good present for all who like to be prepared for the Christmas happy days.
Goal for me is an are near 184.
Does not constitute a recommendation.
#investing...
With PCE being good I think the market will really pump
$MED is breaking out of a triangle and looks like it's trying for more.
$105 short term $107 as well.
Good luck
Medifast is a really strong company fundamentally and it is following the elliot wave pattern perfectly, just completing stage C. We might expect a long term upward trend from this stock. The best time to enter is when we see a cross in the mansfield indicator.
Hello my dear subscribers
Finally I am back with new investing candidates.
Today we will talk about Medifast Inc.
It is personal services company, which made own product OPTAVIA for peoples, which want change their lifestyle and habbits on healthy and strong.
Levels for entry are here:
From 1-year profile we have 2 levels.
First level is at 188.42 to 197 USD....
Fundamentally, this company meets most of the criteria for multiple baggers. Yes, it already is, in fact, a 100 bagger. But given the long term and current growth rates, it still has huge potential. P/E is much lower than the CAGR of earnings per share. It's a bargain at the current price.
The quarter results, that came in yesterday: revenue growth 52% YoY. EPS...
A Bullish Trend Line Cross
Medifast has just completed a bullish upward move across a resistance trend line. I've purchased a July 16 call option and also bought some shares. I'm hoping it will move up as decisively as it recently moved down, hitting $290 by early July.
For confirmation, look for a candle close above the trend line today. If price closes the...
$MED surprises with Earnings report.
Unlike tech and growth stocks, it breaks out 12%+ to $252.
Low volume options but low float.
Potential entry on the next Fibonacci level ($242) towards ATH.
Happy Trading, from CJ -- aka the greatest FURU.
To find out more about The Ultimate Stock Indicator on Tradingview, please check my public profile. 🚀🚀🚀🚀
MED Broke out today from previous high on Jan 22, 2020. Up days have higher volume. Short Interest: 31.62%. This one could see a short squeeze.
Long @120.35
MED is bearish impulse move and based on my wave appears to be headed lower. I have a Wave 5 target of minimally 87 but could reach 85 in the next month
